PATENT CLAIM ANALYSIS

Application Number: 16345279
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["530", "387900"]

Abstract:
The invention relates to anti-Tau nanobodies.

Claim (Index 4):
The nanobody as claimed in  claim 1 , said nanobody comprising the amino acid sequences:\n (i) GRTFSX 1 X 2 X 3  (SEQ ID No. 1) as CDR1 in which the amino acid X 1  is S or R, X 2  is D or Y and X 3  is T or A, (ii) ISX 1 SGGX 2 T (SEQ ID No. 2) as CDR2 in which the amino acid X 1  is P or R and X 2  is S or V, and (iii) NRDPKYGNTRY (SEQ ID No. 5) or TARRRISGTPQWHY (SEQ ID No. 8) as CDR3.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 100.0
- Lexical Diversity: 1.0
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14154954', '14705615', '15337964', '14348918', '15045804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6695718183443374
- 35 USC 102 Novelty (BERT): 0.5047860053488264
- Combined Prediction Score: 0.6530932370447863
- Mean Citation Score: 260.888852
- Max Citation Score: 266.6617
- Similarity Product: 183.02176052877903

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test